Skip to content

A randomized controlled clinical trial of acupoint application of Chinese medicine for suspected asthma

Clinical epidemiological investigation of suspected asthma and randomized controlled clinical trial of acupoint application of Chinese medicine for suspected asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008941
Enrollment
Unknown
Registered
2016-07-29
Start date
2016-08-01
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

acupoint application treatment group:Acupoint application therapy of Chinese medicine
placebo-controlled group:Placebo of Acupoint application therapy

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years, both men and women; 2. Meet the diagnostic criteria of suspected asthma; 3. The chest X-ray is basically normal; 4. The result of induced sputum showed EOS%<2.5%; 5. Patients have informed consent.

Exclusion criteria

Exclusion criteria: 1. Previously diagnosed as bronchial asthma, cough variant asthma or chest tightness variant asthma; 2. Patients with COPD, bronchiectasis, interstitial lung disease, activity of pulmonary tuberculosis disease; 3. TCM syndrome differentiation with Yin-Deficiency and Fire-Hyperactivity as the main syndrome; 4. Allergic to the traditional Chinese medicine ingredients contained in the treatment drug; 5. Patients with a serious heart, liver, kidney and blood system diseases; 6. Pregnant or lactating women; 7. Psychiatric patients.

Design outcomes

Primary

MeasureTime frame
Incidence of asthma;

Secondary

MeasureTime frame
The negative rate of suspected asthma;Assessment of airway responsiveness;SF-36;Total serum immunoglobulin E;ECP;The effective rate of symptomatic improvement;

Countries

China

Contacts

Public ContactYuanbin Chen

Guangdong Provincial Hospital of Chinese Medicine

chenyuanbin110@163.com+86 15920174645

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026